Literature DB >> 26748860

Vaccine-mediated immunity to experimental Mycobacterium tuberculosis is not impaired in the absence of Toll-like receptor 9.

Archana Gopalakrishnan1, Jillian Dietzold1, Padmini Salgame2.   

Abstract

Accumulating evidence indicates that inflammatory signals required for maximizing effector T cell generation have opposing effects on the development of memory T cell precursors. Toll-like receptor (TLR)2, and TLR9 significantly contribute to the inflammatory milieu and therefore in this study we examined whether the absence of TLR9 alone or the combined absence of TLR2 and TLR9 would affect vaccine-mediated immunity to Mtb. We found that TLR9KO and TLR2/9DKO mice vaccinated with a live Mtb auxotroph, akin to vaccinated WT mice, exhibited early control of Mtb growth in the lungs compared to their naïve counterparts. The granulomatous response, IFNγ production and cellular recruitment to the lungs were also similar in all the vaccinated groups of mice. These findings indicate that there is minimal contribution from TLR2 and TLR9 in generating memory immunity to Mtb with live vaccines. Defining the innate milieu that can drive maximal memory T cell generation with a tuberculosis vaccine needs further inquiry.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-12; Memory immunity; Mycobacterium tuberculosis; Toll-like receptor 9; Vaccination

Mesh:

Substances:

Year:  2015        PMID: 26748860      PMCID: PMC4792693          DOI: 10.1016/j.cellimm.2015.12.009

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  50 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.

Authors:  Naofumi Takemoto; Andrew M Intlekofer; John T Northrup; E John Wherry; Steven L Reiner
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells.

Authors:  Marion Pepper; Antonio J Pagán; Botond Z Igyártó; Justin J Taylor; Marc K Jenkins
Journal:  Immunity       Date:  2011-10-20       Impact factor: 31.745

4.  An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells.

Authors:  Weiguo Cui; Ying Liu; Jason S Weinstein; Joseph Craft; Susan M Kaech
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

5.  Development of a secondary immune response to Mycobacterium tuberculosis is independent of Toll-like receptor 2.

Authors:  Amanda McBride; Kamlesh Bhatt; Padmini Salgame
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

6.  TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.

Authors:  Anneliese S Tyne; John Gar Yan Chan; Erin R Shanahan; Ines Atmosukarto; Hak-Kim Chan; Warwick J Britton; Nicholas P West
Journal:  Vaccine       Date:  2013-07-20       Impact factor: 3.641

Review 7.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.

Authors:  Clifford V Harding; W Henry Boom
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

8.  The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation.

Authors:  Hiroyuki Saiga; Natalie Nieuwenhuizen; Martin Gengenbacher; Anne-Britta Koehler; Stefanie Schuerer; Pedro Moura-Alves; Ina Wagner; Hans-Joachim Mollenkopf; Anca Dorhoi; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2014-12-11       Impact factor: 5.226

9.  Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells.

Authors:  Antonio Gigliotti Rothfuchs; Andre Bafica; Carl G Feng; Jackson G Egen; David L Williams; Gordon D Brown; Alan Sher
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

10.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

Review 2.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

Review 3.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

4.  The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis.

Authors:  Willem J du Plessis; Léanie Kleynhans; Nelita du Plessis; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Katharina Ronacher; Novel N Chegou; Gerhard Walzl; Andre G Loxton
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

Review 5.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.